Munich
Germany
18
2025-06-19
The entities that hold a legal rights for patent applications filed by inventor Endell Jan:
Jan Endell from Munich, DE has applied for patents for these inventions. The list has both pending applications and granted patents:
COMBINATIONS AND USES THEREOF
#2 | 2024-05-16SEQUENTIAL ANTI-CD19 THERAPY
#3 | 2024-01-11COMBINATION OF AN ANTI-CD19 ANTIBODY AND A BRUTON'S TYROSINE KINASE INHIBITOR AND USES THEREOF
#4 | 2022-09-08METHODS FOR PREDICTING THERAPEUTIC BENEFIT OF ANTI-CD19 THERAPY IN PATIENTS
#5 | 2022-03-24Combinations and uses thereof
#6 | 2021-05-06ANTI-TUMOR COMBINATION THERAPY COMPRISING ANTI-CD19 ANTIBODY AND GAMMA DELTA T-CELLS
#7 | 2020-07-02COMBINATION OF AN ANTI-CD19 ANTIBODY AND A BRUTON'S TYROSINE KINASE INHIBITOR AND USES THEREOF
#8 | 2020-03-12Treatment for multiple myeloma (MM)
#9 | 2019-08-08COMBINATION OF ANTI CD19 ANTIBODY WITH A BCL-2 INHIBITOR AND USES THEREOF
#10 | 2019-06-27METHODS FOR PREDICTING THERAPEUTIC BENEFIT OF ANTI-CD19 THERAPY IN PATIENTS
#11 | 2019-02-14Treatment for multiple myeloma (MM)
#12 | 2018-08-16Combinations and uses thereof
#13 | 2018-06-07Combination of an anti-CD19 antibody and a Bruton's tyrosine kinase inhibitor and uses thereof
#14 | 2018-01-25Method for the treament of multiple myeloma or non-hodgkins lymphoma with anti-CD38 antibody in combination with thalidomine, lenalidomids, or pomalidomide
#15 | 2016-08-04Method for the treatment of multiple myeloma or non-Hodgkins lymphoma with anti-CD38 antibody and bortezomib or carfilzomib
#16 | 2015-08-27Combinations and uses thereof
#17 | 2015-01-15Combinations and uses thereof
#18 | 2013-11-14Anti-CD38 antibody and lenalidomide or bortezomib for the treatment of multipe myeloma and NHL
528283 ⎘